BURLINGTON, Mass. (AP) — Flexion Therapeutics Inc. (FLXN) on Wednesday reported a loss of $43.6 million in its third quarter.

The Burlington, Massachusetts-based company said it had a loss of $1.15 per share.

The results beat Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of $1.24 per share.

The specialty pharmaceutical companies that specializes in pain relief posted revenue of $7 million in the period, also exceeding Street forecasts. Four analysts surveyed by Zacks expected $5.9 million.

Flexion Therapeutics shares have fallen 43 percent since the beginning of the year. In the final minutes of trading on Wednesday, shares hit $14.27, a fall of 40 percent in the last 12 months.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on FLXN at https://www.zacks.com/ap/FLXN

Automated Insights

(0) comments

Welcome to the discussion.

Keep it Clean. Please avoid obscene, vulgar, lewd, racist or sexually-oriented language.
Don't Threaten. Threats of harming another person will not be tolerated.
Be Truthful. Don't knowingly lie about anyone or anything.
Be Nice. No racism, sexism or any sort of -ism that is degrading to another person.
Be Proactive. Use the 'Report' link on each comment to let us know of abusive posts.
Share with Us. We'd love to hear eyewitness accounts, the history behind an article.